Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Outpatient (ex Primary Care)

 

HBI 2017: Are non-specialised hospitals doomed?

As payers move away from rewarding volume towards rewarding value, care delivery is increasingly organised outside of hospitals. But to what extent is it happening? Speakers at the 2017 HBI conference suggested that while it is too early too announce the death of hospital care, operators are facing some severe disruptions.

HBI 2017: What is changing in the healthcare landscape in Emerging Markets?

Emerging Markets will make up 68% of the global GDP and 59% of global consumer spending growth by 2030. But how is the investment landscape changing, and where is the money flowing to? At the HBI 2017 conference in London, Hedley Goldberg, global head of healthcare services at Rothschild, Chinta Bhagat, head of Global Healthcare at Malaysian investment fund Khazanah Nasional Berhad, a big investor in hospital chain IHH, and Khawar Mann, managing director for healthcare at Abraaj, shared their expert views.

Hygeia adds Gold Cross Hospital to Nigerian network

African investor Hygeia has bought the 35-bed Gold Cross Hospital in Nigeria adding to a growing network centred on the Lagoon Hospital and the country’s largest HMO. We spoke to Lagoon’s CEO, Rajeev Bhandari.

How to make money in the Czech outpatient market

Czech outpatient specialist EUC Group (formerly Euroclinicum) is consolidating the outpatient market, and has just released preliminary results for 2016 and announced another acquisition. Healthcare Nova catches up with Jan Hůlek, one of the directors, to talk about the group’s business strategy and how to make money and grow in the outpatient market.

Intermedica tight lipped about plans to sell, IPO – or both

Intermedica, the private Brazilian payor-provider headquartered in Sao Paulo, Brazil, is refusing to comment on its prospective stock market flotation or sale - telling Healthcare Nova that, at this stage, it is “not allowed to comment on anything to do with IPOs or strategy”. But according to one sources in Brazil, Intermedica may go for a mix of both IPO and sale.

Find Us